Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Mst1-mediated phosphorylation of Bcl-xL is required for myocardial reperfusion injury
Michinari Nakamura, Peiyong Zhai, Dominic P. Del Re, Yasuhiro Maejima, Junichi Sadoshima
Michinari Nakamura, Peiyong Zhai, Dominic P. Del Re, Yasuhiro Maejima, Junichi Sadoshima
View: Text | PDF
Research Article Cardiology Cell biology

Mst1-mediated phosphorylation of Bcl-xL is required for myocardial reperfusion injury

  • Text
  • PDF
Abstract

Mst1 is a central Ser-Thr kinase in the Hippo pathway, which promotes apoptosis and inhibits cell proliferation. We have shown previously that, in cardiomyocytes, oxidative stress activates Mst1 at mitochondria, where Mst1 phosphorylates Bcl-xL at Ser14, inducing dissociation of Bcl-xL from Bax and thereby promoting apoptosis. However, the functional significance of Ser14 phosphorylation of endogenous Bcl-xL in vivo remains elusive. We generated knockin (KI) mice in which Ser14 of Bcl-xL is replaced with Ala. KI mice were born at the expected Mendelian ratio, and adult KI mice exhibited normal cardiac morphology and function at baseline. However, KI mice were protected from myocardial ischemia/reperfusion (I/R) injury and exhibited reduced cardiomyocyte apoptosis. Although suppression of endogenous Mst1 also reduced I/R injury, there was no additive protective effect when Mst1 was inhibited in KI mice. The development of dilated cardiomyopathy induced by cardiac-specific overexpression of Mst1 was also ameliorated in KI mice. Lats2 and YAP, two other key components of the Hippo pathway, were not affected in KI mice. These results suggest that Ser14 phosphorylation of Bcl-xL plays an essential role in mediating both cardiomyocyte apoptosis and myocardial injury by acting as a key downstream mediator of Mst1 independently of the canonical Hippo pathway.

Authors

Michinari Nakamura, Peiyong Zhai, Dominic P. Del Re, Yasuhiro Maejima, Junichi Sadoshima

×

Figure 3

The protective effect of S14A knockin is part of the same pathway as that of Mst1 inhibition during ischemia/reperfusion.

Options: View larger image (or click on image) Download as PowerPoint
The protective effect of S14A knockin is part of the same pathway as tha...
(A) Immunoblots showing p-Bcl-xL (S14) and total Bcl-xL. WT, Tg–dominant-negative–Mst1 (Tg-DN-Mst1), and bigenic mice generated by crossing knockin (KI) and Tg-DN-Mst1 mice (KI×Tg-DN-Mst1) were subjected to 30 minutes of ischemia and 30 minutes of reperfusion for protein expression analyses or 24 hours of reperfusion for measuring infarct size and TUNEL staining. (B) Representative images showing myocardial infarction (MI) and area at risk (AAR). White myocardium represents the infarct area. Scale bar: 1 mm. (C) Quantification of percentage AAR and percentage MI. Bigenic mice did not show additive protection against ischemia/reperfusion (I/R) compared with KI or Tg-DN-Mst1 mice (n = 5–10). (D) Representative TUNEL (green) and nuclear (blue) staining of the hearts (ischemic area) of the indicated mice following I/R. Scale bar: 50 μm; 10 μm (inset). (E) Quantification of TUNEL-positive nuclei (%) (n = 4–6). Data are mean ± SEM. *P < 0.05, **P < 0.001, 1-way ANOVA followed by the Newman-Keuls post-hoc analysis.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts